The ectodermal loss of ARHGAP29 alters epithelial morphology and organization and disrupts murine palatal development

Insights

RhoA GTPase Activating Protein 29 (ARHGAP29) is crucial for preventing cleft palate (CP) in mice. Loss of ARHGAP29 in specific embryonic tissues disrupts palatal fusion, leading to CP, highlighting its essential role in development.

Area of Science:

  • Developmental Biology
  • Genetics
  • Craniofacial Development

Background:

  • Orofacial clefts, including cleft palate (CP), are common birth defects.
  • CP arises from failed palatal shelf fusion during embryonic development.
  • Mutations in ARHGAP29 are linked to CP, but its specific role is unknown.

Purpose of the Study:

  • To investigate the tissue-specific function of ARHGAP29 during palatogenesis.
  • To provide direct evidence for ARHGAP29's essential role in palatal fusion.

Main Methods:

  • Used tissue-specific deletion of Arhgap29 in mouse models.
  • Analyzed palatal shelf development at embryonic days E14.5 and E18.5.
  • Performed phenotypic analyses of palatal shelf morphology and cellular changes.

Main Results:

  • Ectodermal loss of Arhgap29 delayed palatal shelf fusion and caused significant cleft palate.
  • Loss of Arhgap29 resulted in disorganized, thicker oral epithelium.
  • ARHGAP29 deficiency increased epithelial cell area and upregulated contractility-related proteins.

Conclusions:

  • ARHGAP29 is essential for proper palatal elevation and fusion.
  • Altered oral epithelial morphology and contractility are key mechanisms driving CP in Arhgap29 mutants.
  • ARHGAP29's role is critical during early palatogenesis.

Related Concept Videos